Precision Wealth Strategies, LLC Abb Vie Inc. Transaction History

Precision Wealth Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $2,074 - $2,488	-15 Reduced 0.44%	3,363 $543,000
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $15,299 - $17,548	114 Added 3.49%	3,378 $510,000
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $24,496 - $31,142	178 Added 5.77%	3,264 $497,000
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $187,939 - $233,180	-1,424 Reduced 31.57%	3,086 $500,000
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $69,507 - $87,946	647 Added 16.75%	4,510 $611,000
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $192,796 - $218,853	1,812 Added 88.35%	3,863 $417,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $215,785 - $240,397	2,051 New	2,051 $231,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Precision Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Precision Wealth Strategies, LLC with notifications on news.